Chabiotech Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chabiotech Co Ltd with three other
miscellaneous service companies in Asia:
Shin Nippon Biomedical Laboratories Ltd
sales of 17.84 billion Japanese Yen [US$171.04 million]
of which 66%
was Pre-Clinical Business),
Takara Bio Inc
(25.97 billion Japanese Yen [US$249.04 million]
of which 91%
was Bio support), and
based in Japan
(45.20 billion Japanese Yen [US$433.49 million]
of which 53%
was Cro Business).
Chabiotech Co Ltd reported sales of 393.78 billion Korean Won (US$348.50 million)
December of 2015.
increase of 14.0%
versus 2014, when the company's sales were 345.34 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2013, when Chabiotech Co Ltd
reported sales of 528.12 billion Korean Won.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Chabiotech Co Ltd had sales
of 381.82 billion Korean Won.